ReviewAdvances in experimental medicine and biology2025
Notch Signaling in Drosophila Tumor Models.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Notch pathway represents a juxtacrine signaling pathway, where ligands expressed at the surface of a cell instruct the neighboring cell through the activation of the transmembrane receptor Notch. The Notch pathway controls a wide variety of developmental cell fate decisions and tissue patterning, as well as the biology and differentiation programs of different stem-cell lineages. First described in Drosophila, the Notch pathway is highly conserved throughout evolution, and Notch mutations or Notch pathway alterations have been implicated in an ever-growing set of pathologies, including many cancers where it can act as an oncogene or a tumor-suppressor depending on cancer type and context. Similarly, in Drosophila tumor models, the Notch pathway can either promote or prevent proliferation and tumoral cell behaviors. In this chapter, I will first describe the Notch pathway and its many nodes of regulation, representing as many potential routes to unleash Notch-driven cancers. Then I will review the implication of the Notch pathway and its misregulations in the main larval (imaginal discs, brain) and adult Drosophila tumor models, either as a primary driver or as a contributing factor to tumor development and evolution.
Indexed as
Identifiers
40745134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.